These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21918546)

  • 1. Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.
    Rommelfanger DM; Offord CP; Dev J; Bajzer Z; Vile RG; Dingli D
    Gene Ther; 2012 May; 19(5):543-9. PubMed ID: 21918546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling.
    Wongthida P; Diaz RM; Galivo F; Kottke T; Thompson J; Melcher A; Vile R
    Mol Ther; 2011 Jan; 19(1):150-8. PubMed ID: 20959810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer.
    Wongthida P; Diaz RM; Galivo F; Kottke T; Thompson J; Pulido J; Pavelko K; Pease L; Melcher A; Vile R
    Cancer Res; 2010 Jun; 70(11):4539-49. PubMed ID: 20484025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus.
    Galivo F; Diaz RM; Thanarajasingam U; Jevremovic D; Wongthida P; Thompson J; Kottke T; Barber GN; Melcher A; Vile RG
    Hum Gene Ther; 2010 Apr; 21(4):439-50. PubMed ID: 19922169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamide.
    Willmon C; Diaz RM; Wongthida P; Galivo F; Kottke T; Thompson J; Albelda S; Harrington K; Melcher A; Vile R
    Mol Ther; 2011 Jan; 19(1):140-9. PubMed ID: 20978474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus.
    Wongthida P; Diaz RM; Pulido C; Rommelfanger D; Galivo F; Kaluza K; Kottke T; Thompson J; Melcher A; Vile R
    Hum Gene Ther; 2011 Nov; 22(11):1343-53. PubMed ID: 21366404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma.
    Galivo F; Diaz RM; Wongthida P; Thompson J; Kottke T; Barber G; Melcher A; Vile R
    Gene Ther; 2010 Feb; 17(2):158-70. PubMed ID: 20016540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus.
    Diaz RM; Galivo F; Kottke T; Wongthida P; Qiao J; Thompson J; Valdes M; Barber G; Vile RG
    Cancer Res; 2007 Mar; 67(6):2840-8. PubMed ID: 17363607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Macrophages Plasticity Following Tumour-Immune Interactions During Oncolytic Therapies.
    Eftimie R; Eftimie G
    Acta Biotheor; 2019 Dec; 67(4):321-359. PubMed ID: 31410657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic combination virotherapy for melanoma with tumor antigen-expressing vesicular stomatitis virus and adoptive T-cell transfer.
    Rommelfanger DM; Wongthida P; Diaz RM; Kaluza KM; Thompson JM; Kottke TJ; Vile RG
    Cancer Res; 2012 Sep; 72(18):4753-64. PubMed ID: 22836753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment.
    Koske I; Rössler A; Pipperger L; Petersson M; Barnstorf I; Kimpel J; Tripp CH; Stoitzner P; Bánki Z; von Laer D
    Int J Cancer; 2019 Oct; 145(7):1958-1969. PubMed ID: 30972741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
    Shin EJ; Wanna GB; Choi B; Aguila D; Ebert O; Genden EM; Woo SL
    Laryngoscope; 2007 Feb; 117(2):210-4. PubMed ID: 17204993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors.
    Qiao J; Wang H; Kottke T; Diaz RM; Willmon C; Hudacek A; Thompson J; Parato K; Bell J; Naik J; Chester J; Selby P; Harrington K; Melcher A; Vile RG
    Gene Ther; 2008 Apr; 15(8):604-16. PubMed ID: 18305577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
    Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.
    Falls T; Roy DG; Bell JC; Bourgeois-Daigneault MC
    ILAR J; 2016; 57(1):73-85. PubMed ID: 27034397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy.
    Muik A; Dold C; Geiß Y; Volk A; Werbizki M; Dietrich U; von Laer D
    J Mol Med (Berl); 2012 Aug; 90(8):959-70. PubMed ID: 22286341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.
    Blackham AU; Northrup SA; Willingham M; D'Agostino RB; Lyles DS; Stewart JH
    Surgery; 2013 Mar; 153(3):333-43. PubMed ID: 23102637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
    Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer].
    Hadaschik BA; Zhang K; So AI; Bell JC; Thüroff JW; Rennie PS; Gleave ME
    Urologe A; 2008 Sep; 47(9):1145-51. PubMed ID: 18670747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic tumor cells detection and anti-metastatic potential with vesicular stomatitis virus in immunocompetent murine model of osteosarcoma.
    Johan MP; Kubo T; Furuta T; Sakuda T; Sakaguchi T; Nakanishi M; Ochi M; Adachi N
    J Orthop Res; 2018 Sep; 36(9):2562-2569. PubMed ID: 29637599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.